Early approvals for new treatments, such as those for COVID-19, could get delayed by the standards the FDA used for older drugs, according to a new study
The protein structure facilitates viral entry into host cells making it a key target for vaccine and antiviral drug development, according to the researchers
Forty-one of the candidate drugs from AI VIVO’s top-ranked list for COVID-19 are now in clinical trials for COVID-19 by multiple groups globally
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.